Aristotle Atlantic Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$23.4M |
| 2 |
Boston Scientific
BSX
|
+$17.1M |
| 3 |
Microchip Technology
MCHP
|
+$14.2M |
| 4 |
Analog Devices
ADI
|
+$12.9M |
| 5 |
Eli Lilly
LLY
|
+$11.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$41.1M |
| 2 |
ON Semiconductor
ON
|
+$19.2M |
| 3 |
Abbott
ABT
|
+$19M |
| 4 |
Accenture
ACN
|
+$16.9M |
| 5 |
Teleflex
TFX
|
+$15.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.82% |
| 2 | Healthcare | 12.91% |
| 3 | Communication Services | 10.84% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Financials | 9.11% |
Similar funds
Aristotle Atlantic Partners's Q2 2024 Portfolio in Review
As of Q2 2024, Aristotle Atlantic Partners held 96 positions worth $3.09B, up 0.74% from $3.06B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Aristotle Atlantic Partners withdrew a net $163M in Q2 2024, closing 2 positions and reducing 60 holdings. Its most notable exit was ON Semiconductor, an estimated $19.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 41% of assets, up from 37% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Aristotle Atlantic Partners opened a new position in Boston Scientific worth $18M.
- Aristotle Atlantic Partners's largest Q2 2024 buy was Boston Scientific: 233,209 shares worth $18M.
- Aristotle Atlantic Partners added most to Apple in Q2 2024, an estimated $23.4M increase.
- Aristotle Atlantic Partners's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $41.1M.
- Aristotle Atlantic Partners fully exited ON Semiconductor in Q2 2024, selling an estimated $19.2M.
- Aristotle Atlantic Partners's ten largest holdings make up 50% of its $3.09B portfolio in Q2 2024.
- Aristotle Atlantic Partners opened 4 new positions and closed 2 in Q2 2024.
- Aristotle Atlantic Partners's portfolio value rose 0.74% quarter-over-quarter to $3.09B.
Based on Aristotle Atlantic Partners's 13F filing for Q2 2024, filed 14 Aug 2024.